Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update

Authors
Category Primary study
JournalSwiss Medical Weekly
Year 2021
This article has no abstract
Epistemonikos ID: 3a6e521109dd7aa00be8a2f527f8bb28092ace1a
First added on: Feb 13, 2025